vidarabine has been researched along with 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, CI; MacCoss, M; Matsushita, T; Ryu, EK | 1 |
1 other study(ies) available for vidarabine and 1 beta-d-arabinofuranosylcytosine 5'-diphosphate-l-1,2 dipalmitin
Article | Year |
---|---|
Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Topics: Animals; Biotransformation; Cell Division; Cell Line; Cytarabine; Cytidine Diphosphate Diglycerides; Deamination; Delayed-Action Preparations; Injections, Intraperitoneal; Leukemia L1210; Mice; Neoplasm Transplantation; Prognosis; Ribonucleosides; Technology, Pharmaceutical; Tubercidin; Vidarabine | 1981 |